NX-13


Catalog No. Size PriceQuantity
M15889-2 2 mg solid, 1-2 weeks $155
M15889-10 10 mg solid, 1-2 weeks $215
M15889-100 100 mg solid, 1-2 weeks $435
M15889-C Contact sales@xcessbio.com for quotation $100

Description

NX-13 is a first-in-class, orally active and gut-restricted agent that selectively targets and activates the NLRX1 pathway to induce immunometabolic changes. NX-13 results in lower inflammation and responses in inflammatory bowel disease. NX-13 can be used for the research of crohn's disease and ulcerative colitis.

Product information

CAS Number: 2389235-01-0

Molecular Weight: 399.44

Formula: C24H21N3O3

Chemical Name: 2-{3, 5-bis[(6-methylpyridin-2-yl)oxy]phenoxy}-6-methylpyridine

Smiles: CC1C=CC=C(N=1)OC1=CC(=CC(=C1)OC1=CC=CC(C)=N1)OC1C=CC=C(C)N=1

InChiKey: OPUQKVNCXCWRLR-UHFFFAOYSA-N

InChi: InChI=1S/C24H21N3O3/c1-16-7-4-10-22(25-16)28-19-13-20(29-23-11-5-8-17(2)26-23)15-21(14-19)30-24-12-6-9-18(3)27-24/h4-15H,1-3H3

Technical Data

Appearance: Solid Power

Purity: ≥98% (or refer to the Certificate of Analysis)

Solubility: DMSO : 135 mg/mL (337.97 mM; Need ultrasonic).

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis

Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.

Shelf Life: ≥12 months if stored properly.

Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.

Drug Formulation: To be determined

HS Tariff Code: 382200

How to use

In Vivo:

NX-13 (0, 500, or 1000 mg/kg; oral gavage; 7 days) reduces ALP levels. NX-13 (1 and 10 mg/kg; oral gavage; 0~24 hours) reaches the distal gastrointestinal tract.

Products are for research use only. Not for human use.

Payment & Security

PayPal Venmo

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Estimate shipping

You may also like

Recently viewed